Please use this identifier to cite or link to this item:
|Title:||Olfactory deficits and amyloid-β burden in Alzheimer's disease, mild cognitive impairment, and healthy aging: a PiB PET study.|
|Authors:||Bahar-Fuchs, Alex;Chételat, Gael;Villemagne, Victor L;Moss, Simon;Pike, Kerryn E;Masters, Colin L;Rowe, Christopher C;Savage, Greg|
Department of Nuclear Medicine & Centre for PET, Austin Health, Heidelberg, Victoria, Australia
|Citation:||Journal of Alzheimer's Disease : Jad; 22(4): 1081-7|
|Abstract:||Olfactory deficits and increased amyloid-β (Aβ) burden are observed in people with amnestic mild cognitive impairment (aMCI); both factors may be predictive of Alzheimer's disease (AD). We explored whether olfactory identification is related to in vivo measures of Aβ burden using Pittsburgh Compound B (PiB) PET. Nineteen control, 24 aMCI, and 20 AD participants completed an olfactory identification task and underwent PiB PET scanning. Control participants performed better on olfactory identification and showed lower PiB binding than aMCI patients. There was a significant correlation between both factors when pooling all groups together but not when considering each group separately. In addition, the olfactory identification score did not differ between aMCI participants who were PiB-positive and those who were PiB-negative. We conclude that AD-related olfactory identification deficits are not directly related to Aβ burden.|
|Internal ID Number:||20930316|
Aged, 80 and over
Alzheimer Disease.complications.metabolism.radionuclide imaging
Cognition Disorders.complications.metabolism.radionuclide imaging
Olfaction Disorders.complications.metabolism.radionuclide imaging
|Appears in Collections:||Journal articles|
Files in This Item:
There are no files associated with this item.
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.